Morgan Stanley Vera Therapeutics, Inc. Transaction History

Morgan Stanley

$1.23 Trillion
Q1 2024

A detailed history of Morgan Stanley transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,536,790 shares of VERA stock, worth $58.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,536,790

Previous 994,840 54.48%

Holding current value

$58.4 Million

Previous $15.3 Million 333.11%

% of portfolio

0.01%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$14.91 - $49.14 $8.08 Million - $26.6 Million	541,950 Added 54.48%	1,536,790 $66.3 Million
Q4 2023 Feb 13, 2024	BUY	$9.29 - $16.0 $744,073 - $1.28 Million	80,094 Added 8.76%	994,840 $15.3 Million
Q3 2023 Nov 15, 2023	SELL	$13.71 - $19.64 $730,729 - $1.05 Million	-53,299 Reduced 5.51%	914,746 $12.5 Million
Q2 2023 Aug 14, 2023	BUY	$6.11 - $17.83 $5.67 Million - $16.5 Million	927,377 Added 2280.36%	968,045 $15.5 Million
Q1 2023 May 15, 2023	BUY	$5.41 - $18.3 $135,872 - $459,604	25,115 Added 161.48%	40,668 $315,000

Q4 2022 Feb 14, 2023	SELL	$15.74 - $22.19 $116,586 - $164,361	-7,407 Reduced 32.26%	15,553 $300,000
Q3 2022 Nov 14, 2022	BUY	$13.27 - $22.31 $258,698 - $434,933	19,495 Added 562.63%	22,960 $489,000
Q2 2022 Oct 27, 2022	SELL	$12.82 - $23.4 $192,979 - $352,240	-15,053 Reduced 81.29%	3,465 $47,000
Q2 2022 Aug 15, 2022	SELL	$12.82 - $23.4 $192,979 - $352,240	-15,053 Reduced 81.29%	3,465 $47,000
Q1 2022 Oct 27, 2022	BUY	$17.8 - $28.06 $267,943 - $422,387	15,053 Added 434.43%	18,518 $435,000
Q1 2022 May 13, 2022	SELL	$17.8 - $28.06 $145,479 - $229,334	-8,173 Reduced 30.62%	18,518 $435,000
Q4 2021 Feb 14, 2022	BUY	$15.01 - $35.8 $70,321 - $167,723	4,685 Added 21.29%	26,691 $714,000
Q3 2021 Nov 15, 2021	BUY	$13.71 - $30.6 $301,702 - $673,383	22,006 New	22,006 $382,000

Others Institutions Holding VERA

# of Institutions

173

Shares Held

52.7M

Call Options Held

117K

Put Options Held

290K

View Full List

About Vera Therapeutics, Inc.

Ticker VERA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,042,300
Market Cap $1.03B
Description
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...

More about VERA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account